Deuterium magnetic resonance spectroscopy enables noninvasive metabolic imaging of tumor burden and response to therapy in low-grade gliomas. Read more about Deuterium magnetic resonance spectroscopy enables noninvasive metabolic imaging of tumor burden and response to therapy in low-grade gliomas.
Loss of ATRX suppresses anti-tumor immunity. Read more about Loss of ATRX suppresses anti-tumor immunity.
CD55, a potential immunotherapeutic target for MYCN-amplified neuroblastoma. Read more about CD55, a potential immunotherapeutic target for MYCN-amplified neuroblastoma.
Liquid biopsy in gliomas: A RANO review and proposals for clinical applications. Read more about Liquid biopsy in gliomas: A RANO review and proposals for clinical applications.
A molecularly integrated grade for meningioma. Read more about A molecularly integrated grade for meningioma.
Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging. Read more about Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging.
The benefit of early surgery on overall survival in incidental low-grade glioma patients: A multicenter study. Read more about The benefit of early surgery on overall survival in incidental low-grade glioma patients: A multicenter study.
Treat the VTE and worry less about the hemorrhage: A sigh of relief or is the jury still out for therapeutic anticoagulation in high-grade glioma? Read more about Treat the VTE and worry less about the hemorrhage: A sigh of relief or is the jury still out for therapeutic anticoagulation in high-grade glioma?
External controls to improve on glioblastoma clinical trials. Read more about External controls to improve on glioblastoma clinical trials.
Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice. Read more about Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice.
